Control of massive bleeding in dengue hemorrhagic fever with severe thrombocytopenia by use of intravenous anti-D globulin

Pediatric Blood and Cancer

Volumn 51, Issue 6, 2008, Pages 812-813

  Yadav, Satya P ^a   Sachdeva, Anupam ^a   Gupta, Dhiren ^a   Sharma, Sunil D ^a   Kharya, Gaurav ^a  

^a SIR GANGA RAM HOSPITAL   (India)

Author keywords

Critical care medicine; Infectious disease; Thrombocytopenia

Indexed keywords

BLOOD CLOTTING FACTOR 7; DOPAMINE; KAMRHOD IV; RHESUS D ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; APHERESIS; ARTICLE; ARTIFICIAL VENTILATION; BLOOD PRESSURE; CASE REPORT; COLLOID; COMORBIDITY; CRYOPRECIPITATION; CRYSTALLOID; DENGUE; FEMALE; GASTROINTESTINAL HEMORRHAGE; GENERAL CONDITION DETERIORATION; HUMAN; HYPOKINESIA; HYPOTENSION; INTERNATIONAL NORMALIZED RATIO; INTRAVENOUS ADMINISTRATION; LUNG HEMORRHAGE; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTHROMBIN TIME; RESPIRATORY DISTRESS; SINGLE DRUG DOSE; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT RESPONSE;

ADOLESCENT; CHILD, PRESCHOOL; DENGUE HEMORRHAGIC FEVER; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMORRHAGE; HUMANS; IMMUNOLOGIC FACTORS; LUNG DISEASES; MALE; RHO(D) IMMUNE GLOBULIN; THROMBOCYTOPENIA;

EID: 56749158865     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21708     Document Type: Article

References (10)

1. World Health Organization. Dengue hemorrhagic fever: Diagnosis, treatment and control, 2nd edition. Geneva: WHO Geneva Publication; 1997. pp 12-23.
2. World Health Organization. Dengue/dengue hemorrhagic fever. Wkly Epidemiol Rec 2000;75:193-196.
3. Saito M, Oishi K, Inoue S, et al. Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections. Clin Exp Immunol 2004;138:299-303.
4. Mitrakul C. Hemostatic and platelet kinetic studies in dengue hemorrhagic fever. Am J Trop Med Hyg 1979;26:975-984.
5. Boonpucknavig S. Demonstration of dengue antibody complexes on the surface of platelet from patients with dengue hemorrhagic fever. Am J Trop Med Hyg 1979;28:881-884.
6. Mitrakul C, Poshyachinda M, Futrakul P, et al. Hemostatic and platelet kinetic studies in dengue hemorrhagic fever. Am J Trop Med Hyg 1977;26:975-984.
7. Isarangkura PB, Pongpanich B, Pintadit P, et al. Hemostatic derangement in dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 1987;18:331-339.
8. Krishnamurit C, Kalayanarooj S, Cutting MA, et al. Mechanism of hemorrhage in dengue without circulatory collapse. Am J Trop Med Hyg 2001;65:840-847.
9. Chuansumrit A, Wangruangsatid S, Lektrakul Y, et al. Control of bleeding in children with dengue hemorrhagic fever using recombinant activated factor VII: A randomized, double blind, placebo-controlled study. Blood Coagul Fibrinolysis 2005;16:549-555.
10. De Castro RA, de Castro JA, Barez MY, et al. Thrombocytopenia associated with dengue hemorrhagic fever responds to intravenous administration anti D (Rh-D) antiglobulin. Am J Trop Med Hyg 2007;76:737-742.